The broader enforcement focus: Botox-type products, ophthalmics, clinical trials, recalls The RAPS article also highlights other key enforcement priorities for CDER in 2025: The agency issued 18 warning letters to firms marketing fraudulent or unapproved Botox-type products, warning that such products pose serious safety risks, including potential counterfeiting, incorrect/inactive ingredients, or falsification
Yes, variants like G1793A (rs2274976) can also significantly decrease enzyme function, while others, such as rs9651118 and rs13306560, are associated with positive health outcomes like lower blood pressure or reduced risk of certain diseases
With over four years of clinical experience, Darshana has treated patients across a wide range of settings, including musculoskeletal, neurologic, geriatric, and community rehabilitation
If symptoms persist or worsen despite home care and OTC medicines, do not hesitate to use telehealth services like Doctronic.ai for expert guidance